Efficacy and Safety of MSLN CAR-T in Advanced Malignant Tumors

Clinical trial NCT07399769 · RECRUITING

Trial details

NCT number: NCT07399769
Sponsor: Shenzhen University General Hospital
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Advanced Solid Malignant Tumors (With Positive Expression of MSLN in Tumor Tissue)

Start date: 2024-01-01
Primary completion: 2027-01-30
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.